G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 38.3 HKD 1.11% Market Closed
Market Cap: 41B HKD

Income Statement

Earnings Waterfall
Giant Biogene Holding Co Ltd

Revenue
6.1B CNY
Cost of Revenue
-1.1B CNY
Gross Profit
5B CNY
Operating Expenses
-2.4B CNY
Operating Income
2.6B CNY
Other Expenses
-352.7m CNY
Net Income
2.3B CNY

Income Statement
Giant Biogene Holding Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2023 Jun-2024 Dec-2024 Jun-2025
Revenue
Interest Expense
0
0
0
0
Revenue
3 524
N/A
4 459
+27%
5 539
+24%
6 111
+10%
Gross Profit
Cost of Revenue
(577)
(769)
(992)
(1 115)
Gross Profit
2 947
N/A
3 689
+25%
4 547
+23%
4 996
+10%
Operating Income
Operating Expenses
(1 281)
(1 627)
(2 237)
(2 382)
Selling, General & Administrative
(1 261)
(1 616)
(2 159)
(2 342)
Research & Development
(75)
(90)
(106)
(99)
Other Operating Expenses
56
79
28
60
Operating Income
1 666
N/A
2 062
+24%
2 310
+12%
2 614
+13%
Pre-Tax Income
Interest Income Expense
78
63
147
132
Non-Reccuring Items
1
(0)
1
0
Total Other Income
1
(0)
(0)
1
Pre-Tax Income
1 745
N/A
2 125
+22%
2 458
+16%
2 747
+12%
Net Income
Tax Provision
(297)
(362)
(396)
(483)
Income from Continuing Operations
1 448
1 763
2 062
2 264
Income to Minority Interest
4
5
1
(2)
Net Income (Common)
1 452
N/A
1 768
+22%
2 062
+17%
2 261
+10%
EPS (Diluted)
1.48
N/A
1.74
+18%
2.06
+18%
2.15
+4%